Your prediction
Adamis Pharmaceuticals Corp. Stock
Our community identified positive and negative aspects for Adamis Pharmaceuticals Corp. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Adamis Pharmaceuticals Corp. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Adamis Pharmaceuticals Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Adamis Pharmaceuticals Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Adamis Pharmaceuticals Corp. | - | - | - | - | - | - | - |
| Rockwell Medical Inc. | 0.660% | -6.289% | -0.783% | -19.873% | 12.343% | -57.111% | -91.910% |
| Pacira Pharmaceuticals | 0.000% | 3.061% | 2.538% | -4.717% | -6.481% | -45.989% | -64.248% |
| Twist Bioscience Corp | -3.020% | -6.175% | 0.864% | 19.328% | 46.750% | 228.010% | -63.180% |
Comments
Adamis Pharmaceuticals Co. (NASDAQ: ADMP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ADMP provided by MarketBeat
